OCT 29, 2019 3:33 PM PDT

Immune Protein Prevents Herpes Spreading to the Brain

WRITTEN BY: Kara Marker

An immune protein that was discovered more than two decades ago has been identified as the primary component of a molecular blockade that prevents genital herpes infections from spreading to the nervous system. Scientists involved in this latest research are hopeful that the findings could someday transform into preventative therapies for genital herpes and other inflammatory diseases.

Genital herpes simplex virus 2 (HSV-2) is not to be confused with HSV-1, with is usually characterized as oral herpes and is transmitted by non-sexual means. At least one out of every six people between the ages of 14 and 19 has HSV-2. The disease is transmitted through sexual contact, often even if the person with the virus is not currently experiencing reactivation.

Once infection ensues, the virus spreads to the nervous system where it eventually enters a period of latency. It lives dormantly with periodic reactivations where the infected person experiences genital lesions. New research shows that a specific immune protein is responsible for preventing the virus from continuing through the nervous system and ultimately reaching the brain.

Interleukins are immune proteins vital for relaying cellular messages during the immune response to pathogens. IL-36γ’s role is pro-inflammatory; in 20 years of research, scientists have observed time and time again its role in the inflammatory response during both autoimmunity and pathogenic invasion.

University of Arizona researchers were the first to pinpoint IL-36γ in the female reproductive tract in the context of HSV-2. Most recently, senior author Melissa Herbst-Kralovetz, PhD, explains, they have been evaluating the “extent that this molecule can protect against, or contribute to, genital infection.”

Their study included an experimental group of mice lacking IL-36γ. Without this key immune protein, an HSV-2 infection spread through the nervous system to the brain. In a control group with normal IL-36γ levels, researchers observed “significantly more” protection from HSV-2 neuroinvasion. While the methods by which IL-36γ protects the body from HSV-2 neuroinvasion are still unknown, researchers do know that neutrophil recruitment is part of the story.

Sources: Centers for Disease Control and Prevention, Oncotarget, University of Arizona College of Medicine, Journal of Immunology

About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 06, 2022
Clinical & Molecular DX
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
JUN 06, 2022
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
The gut microbiome refers to the collection of microorganisms that reside within the gut. The gut microbiome is known to ...
MAY 15, 2022
Immunology
Long-Term Antibiotics Raise the Risk of Death From a Systemic Fungal Infection
MAY 15, 2022
Long-Term Antibiotics Raise the Risk of Death From a Systemic Fungal Infection
Infections are common, and many are becoming increasingly hard for clinicians to treat. Antibiotics are often used to tr ...
JUN 08, 2022
Clinical & Molecular DX
Researchers Search for a Treatment for a Lethal Clostridium Bacteria
JUN 08, 2022
Researchers Search for a Treatment for a Lethal Clostridium Bacteria
Clostridium bacteria are a normal component of the gut microbiome. In rare cases, dysbiosis of Clostridium in the body c ...
JUN 06, 2022
Health & Medicine
Stagnant US Cervical Cancer Survival Rates
JUN 06, 2022
Stagnant US Cervical Cancer Survival Rates
According to JAMA Network, despite the overall cancer mortality rate decreasing since the 90s, cervical cancer survival ...
JUL 08, 2022
Immunology
Solving the Mystery of Failed Staph Vaccines Shows How to Make Them Effective
JUL 08, 2022
Solving the Mystery of Failed Staph Vaccines Shows How to Make Them Effective
Some common bacteria like Staphylococcus aureus have both harmless and pathogenic versions. While staph is often harmles ...
JUL 28, 2022
Cancer
Potential Marker for Prostate Cancer Prognosis Identified
JUL 28, 2022
Potential Marker for Prostate Cancer Prognosis Identified
Cytokines, proteins that affect the immune system, can elicit their effects in either a beneficial or an inhibitory capa ...
Loading Comments...